AbbVie Inc.
ABBV
$137.56
-$1.06-0.77%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
5/26/2023
-
Zolmax
5/26/2023
-
Forbes.com Market News
5/26/2023
-
Ticker Report
5/26/2023
-
Zero Hedge
5/25/2023
-
Fool.com Headlines
5/25/2023
-
PR Newswire
5/25/2023
-
Zacks Investment Research
5/25/2023
-
Zacks Investment Research
5/25/2023
-
Insider Monkey
5/25/2023
-
Insider Monkey
5/24/2023
-
Zacks Investment Research
5/24/2023
-
Stock Options Channel
5/24/2023
-
Insider Monkey
5/24/2023
-
Insider Monkey
5/24/2023
-
PR Newswire
5/24/2023
-
Zacks Investment Research
5/24/2023
-
Tickeron - Stocks
5/23/2023
-
Benzinga
5/23/2023
-
Zacks Investment Research
5/23/2023
-
ETF Channel
5/23/2023
-
Zacks Investment Research
5/22/2023
-
Benzinga
5/22/2023
-
Zacks Investment Research
5/22/2023
-
Simply Wall St
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, May 5, 2023
Period Date
Friday, March 31, 2023
Next Filing
Beginning of August (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
Dividend Per Share (TTM)
Corporate Info
Website
Phone Number
847 932 7900
Address
1 North Waukegan Road
North Chicago, IL 60064-6400
North Chicago, IL 60064-6400
Country
Year Founded
Business Description
Sector
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, a therapy administered as an injection for autoimmune, intestinal Behçet's diseases...
more
